Nuvation Bio Inc.
NUVB · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,266,854 | $664,455 | $595,957 | $896,244 |
| - Cash | $98,897 | $247,970 | $47,977 | $35,723 |
| + Debt | $10,459 | $203,367 | $11,413 | $8,915 |
| Enterprise Value | $1,178,416 | $619,852 | $559,393 | $869,436 |
| Revenue | $13,120 | $4,833 | $3,084 | $5,711 |
| % Growth | 171.5% | 56.7% | -46% | – |
| Gross Profit | $9,771 | $2,257 | $990 | $1,495 |
| % Margin | 74.5% | 46.7% | 32.1% | 26.2% |
| EBITDA | -$54,757 | -$58,230 | -$52,872 | -$49,137 |
| % Margin | -417.4% | -1,204.8% | -1,714.4% | -860.4% |
| Net Income | -$55,792 | -$59,007 | -$53,236 | -$49,445 |
| % Margin | -425.2% | -1,220.9% | -1,726.2% | -865.8% |
| EPS Diluted | -0.16 | -0.17 | -0.16 | -0.15 |
| % Growth | 5.9% | -6.3% | -6.7% | – |
| Operating Cash Flow | -$52,889 | -$48,178 | -$42,627 | -$46,302 |
| Capital Expenditures | -$12 | -$181 | -$72 | $13 |
| Free Cash Flow | -$52,901 | -$48,359 | -$42,699 | -$46,289 |